| |
-Q Fever Antibody Profile (QFEVR)
-Quad
-Quad Screen, Maternal (TQUAD)
-Qualitative Beta Subunit hCG, Urine
-Qualitative Immunoglobulins
-QuantiFERON-TB Gold (QFT)
-Quantitative Bence Jones Protein
-Quantitative Beta Subunit hCG
-Quantitative Fibrinogen
-Quantitative IgE
-Quantitative Immunoglobulins
-Quantitative TG
-Quantitative Tissue Culture
-Quantitative Urine Protein
-Quick-Cult®
-Quinidine (QUIN)
|
|
|
|
Print |
| Q Fever Antibody Profile |
| |
| Includes: |
Antibodies to Coxiella burnetii: • IgG, phase 1 and phase 2 • IgA, phase 1 and phase 2 • IgM, phase 1 and phase 2 |
| |
| CPT: |
86638 (x6) |
| |
| Alternate Name: |
Coxiella burnetii Titer |
| |
| Methodology: |
Indirect Fluorescent Antibody (IFA) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Gold top (serum separator) tube Special Instructions and/or Comments: Refrigerate Reference Range: <1:16 for all assays Clinical Utility: Utilized as an aid in the diagnosis of Q Fever infection. The presence of phase 2 antigen is indicative of acute disease, while phase 1 is indicative of chronic disease. IgG class antibody titer appears early in disease, reaching maximum phase 2 titers by 8 weeks and remaining elevated for a year or more. In chronic granulomatous hepatitis, IgG titers to both phase 1 and 2 antigens are elevated. |
| |
Print |
| Quad |
| |
| See Quad Screen, Maternal Serum |
Print |
| Quad Screen, Maternal |
| |
| Includes: |
• Maternal Serum AFP (MsAFP) • Unconjugated esteriol (uE3) • Total BHCG (BhCG) • Inhibin A • Interpretive Report: Gestational age must be between 15 and 22 weeks (by ultrasound) for newral tube interpretation; 16 to 18 weeks is optimal. Down syndrome and trisomy 18 interpretation is provided for specimens that are between 14 and 22 weeks, 6 days gestation. |
| |
| CPT: |
82105, 82677, 84702, 86336) |
| |
| Alternate Name: |
Second Semester Maternal Quad Screen |
| |
| Methodology: |
Two site Immunoenzymatic (Sandwich and Competitive Assay) |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Gold top (serum separator) tube Specimen must be accompanied by a completed “Second Trimester Maternal Screening Alpha Fetoprotein (AFP)/Quad Screen Patient Information Sheet.” All 10 questions MUST be completed. Collection: Testing is performed on pregnant women at 15 to 23 weeks of gestational age. Special Instructions and/or Comments: Refrigerate Reference Range: Accompanies Report Clinical Utility: Useful for prenatal screening for open neural tube defect (AFP ONLY), Down Syndrome (AFP, hCG, uE(3), and inhibin A) and trisomy 18 (AFP, hCG, uE(3)). |
| |
Print |
| QuantiFERON-TB Gold |
| |
| CPT: |
86480 |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELSIA) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
2-9 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mLwhole blood in TB Antigen Tube AND 1 mLwhole blood in NIL Control Tube AND 1 mLwhole blood in Mitogen Control Tube • 3 tubes MUST be collected and MUST be filled to the black line on the tube. • DO NOT centrifuge, refrigerate or freeze samples |
| |
| Special Instructions and/or Comments: |
• All 3 tubes MUST be filled to the black line AND SHAKEN AFTER COLLECTION UNTIL FROTHING OCCURS. • Blood MUST be collected in tubes specific for this test. • Tubes MUST be maintained at room temperature and delivered to the laboratory as soon as possible • No more than 15 hours may elapse between time of collection and time of receipt in the laboratory Tubes can be requested by contacting our Customer Care Department at 610-402-8170. |
| |
| Reference Range: |
| Negative, M. tuberculosis infection is NOT likely. |
| |
| Clinical Utility: |
| QuantiFERON-TB Gold is approved for use as an aid in diagnosing M. Tuberculosis infection, including both latent tuberculosis infection (LTBI) and TB disease. The CDC recommends that the Quanti-FERON-TB Gold can be used in place of tuberculin skin testing (TST) in all circumstances. The QuantiFERON-TB Gold test is not affected by previous vaccination with bacille Calmette-Guerin (BCG) and can be used for those patients, unlike the TST. |
| |
Print |
| Qualitative Immunoglobulins |
| |
| See IEP/IFE Profile, Comprehensive |
Print |
| Quantitative Bence Jones Protein |
| |
| See Free Light Chains, Quantitative, 24- Hour Urine |
Print |
| Quantitative Beta Subunit hCG |
| |
| See Beta Human Chorionic, Gonadotropin, Serum |
Print |
| Qualitative Beta Subunit hCG, Urine |
| |
| See Beta Human Chorionic , Gonadotropin, Urine |
Print |
| Quantitative Fibrinogen |
| |
| See Fibrinogen, Plasma |
Print |
| Quantitative IgE |
| |
| See Immunoglobulin E, Total |
Print |
| Quantitative Immunoglobulins |
| |
| See Immunoglobulin Profile 1 |
| See Immunoglobulin Profile 2 |
Print |
| Quantitative TG |
| |
| See Thyroglobulin Profile |
Print |
| Quantitative Tissue Culture |
| |
| See Culture, Tissue, Quantitative |
Print |
| Quantitative Urine Protein |
| |
| See Protein, Total, Urine |
Print |
| Quick-Cult® |
| |
| See Occult Blood, Stool |
Print |
| Quinidine |
| |
| CPT: |
80194 |
| |
| Methodology: |
Immunoassay (IA) |
| |
| Testing Schedule: |
Routine |
| |
| Report Available: |
2-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Red top tube, no serum separator Reference Range: Therapeutic: ....................2-5 µg/mL Toxic: ............................>6 µg/mL Clinical Utility: Useful for monitoring therapy and assessing toxicity. |
| |
|